J Korean Radiol Soc.  1997 Oct;37(4):589-595.

Superselective Intraarterial Chemotherapy into Bilateral Uterine Arteries in Uterine Cervical Carcinomas

Affiliations
  • 1Department of Radiology, Seoul National University College of Medicine.

Abstract

PURPOSE
To assess the efficacy of superselective intra-arterial chemotherapy (SSIAC) via the bilateral uterine arteries in cases of cervical carcinoma.
MATERIALS AND METHODS
Eighteen patients with stage IIa (n=10), IIb (n=7), or IIIa (n=1) cervical carcinoma underwent one (n=2) or two (n=16) courses of preoperative SSIAC with Vincristine, Cisplatin, and Mitomycin C. We estimated the extent of reduction of tumor volume and improvement of stage, comparing pre-SSIAC MRI to postoperative results. Tumor vascularity, as seen on uterine arteriography, and procedural complications, were also evaluated.
RESULTS
A marked reduction in tumor volume was observed in all patients, an average reduction volume of 94.7%. Improvement of stage was noted in 16 patients, and in six of these, no residual viable tumor or microinvasive residual tumor was seen. On angiography, tumor hypervascularity was demonstrated in seven patients, but its degree was not substantially related to therapeutic response. In no case did significant systemic complications of result from chemotherapy; in one patient, however, we experienced a serious complication of necrotizing cystitis due to malpositioning of a catheter in the superior vesical artery.
CONCLUSION
SSIAC via the bilateral uterine arteries is an effective complementary modality for the treatment of various stages of cervical carcinoma.

Keyword

Arteries, chemotherapeutic infusion; Arteries, uterine; Uterine neoplasms, angiography

MeSH Terms

Angiography
Arteries
Catheters
Cisplatin
Cystitis
Drug Therapy*
Humans
Magnetic Resonance Imaging
Mitomycin
Neoplasm, Residual
Tumor Burden
Uterine Artery*
Vincristine
Cisplatin
Mitomycin
Vincristine
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr